Chronic Myeloproliferative Disorders Withdrawn Phase 1 / 2 Trials for Edetic acid (DB00974)

IndicationStatusPhase
DBCOND0028462 (Chronic Myeloproliferative Disorders)Withdrawn1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs